Download MendeleyPriming antibody responses to the fusion peptide in rhesus macaques.
Cottrell, C.A., Pratap, P.P., Cirelli, K.M., Carnathan, D.G., Enemuo, C.A., Antanasijevic, A., Ozorowski, G., Sewall, L.M., Gao, H., Allen, J.D., Nogal, B., Silva, M., Bhiman, J., Pauthner, M., Irvine, D.J., Montefiori, D., Crispin, M., Burton, D.R., Silvestri, G., Crotty, S., Ward, A.B.(2024) NPJ Vaccines 9: 126-126
- PubMed: 38997302
- DOI: https://doi.org/10.1038/s41541-024-00918-9
- Primary Citation of Related Structures:
8SWV, 8SWW, 8SWX, 8T2E, 8T2F - PubMed Abstract:
Immunodominance of antibodies targeting non-neutralizing epitopes and the high level of somatic hypermutation within germinal centers (GCs) required for most HIV broadly neutralizing antibodies (bnAbs) are major impediments to the development of an effective HIV vaccine. Rational protein vaccine design and non-conventional immunization strategies are potential avenues to overcome these hurdles. Here, we report using implantable osmotic pumps to continuously deliver a series of epitope-targeted immunogens to rhesus macaques over the course of six months to prime and elicit antibody responses against the conserved fusion peptide (FP). GC responses and antibody specificities were tracked longitudinally using lymph node fine-needle aspirates and electron microscopy polyclonal epitope mapping (EMPEM), respectively, to show antibody responses to the FP/N611 glycan hole region were primed, although exhibited limited neutralization breadth. Application of cryoEMPEM delineated key residues for on-target and off-target responses that can drive the next round of structure-based vaccine design.
Organizational Affiliation:
Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.
